Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 2
Submit an article Journal homepage
201
Views
133
CrossRef citations to date
0
Altmetric
Research Article

Vitamin D Status, Parathyroid Hormone and Bone Mineral Density in Patients with Inflammatory Bowel Disease

J. Jahnsen
,
J. A. Falch
,
P. Mowinckel
&
E. Aadland
Pages 192-199 | Published online: 08 Jul 2009

  • Andreassen H, Rungby J, Dahleiup JF, Mosekilde L. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 1997:32:1247-55.
  • Compston JE. Review article: osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995;9: 237-50.
  • Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study [see comments]. Gut 1997;40:313-9.
  • Compston JE, Creamer B. Plasma levels and intestinal absorption of 25-hydroxyvhami n D in patients with small bowel resection. Gut 1977;18:171-5.
  • Driscoll RH Jr, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982;83:1252-8.
  • Vogelsang H, Ferenci P, Woloszczuk W, Resch H, Herold C, Protz S, et al. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sei 1989:34:1094-9.
  • Andreassen H, Rix M, Brot C, Eskildsen P. Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol 1998;33:1087-93.
  • Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med 1996;239:131 -7.
  • Falch JA, Oftebro H, Haug E. Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25hydroxyvitamin D, 1,25-dihydroxyvitami n D, or vitamin Dbinding protein. J Clin Endocrine 1 Metabm 1987;64:836-41.
  • Oftebro H, Falch JA, Holmberg I, Haug E. Validation of a radioreceptor assay for 1,25-dihydroxyvitami n D using selected ion monitoring GC-MS. Clin Chim Acta 1988;176:157-68.
  • Falch JA, Meyer HE. Bone mineral density measured by dual X-ray absorptiometry. Reference values in a Norwegian population. Tidsskr Nor Laegeforen 1996; 116:2299-302.
  • Vogelsang H, Klamert M, Resch H, Ferenci P. Dietary vitamin D intake in patients with Crohn's disease. Wiener Klin Wochenschr 1995;107:578-81.
  • Compston JE, Horton LW. Oral 25-hydroxyvitami n D3 in treatment of osteomalacia associated with ileal resection and cholestyramine therapy. Gastroenterology 1978;74(5 Pt l):900-2.
  • Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by longterm oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995;7:609-14.
  • McKenna MJ, Freaney R. Secondary hyperparathyroidis m in the elderly: means to defining hypovitaminosis D. Osteoporosis Int 1998;8 Suppl 2:S3-6.
  • Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108:41722.
  • Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Int Med 2000;247:63-70.
  • Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987;28:410-5.
  • Martin A, Fries W, Luisetto G, Mussolin L, Plebani M, Giacomin D, et al. Bone density and calcium metabolism in patients with long-standing, quiescent Crohn's disease. Eur J Gastroenterol Hepatol 1994;6:611-16.
  • Scharla SH, Minne HW, Lempert UG, Leidig G, Hauber M, Raedsch R, et al. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrine 1 1994; 102: 44-9.
  • Lips P, Netelenbos JC, Jongen MJ, van Ginkel FC, Althuis AL, van Schaik CL, et al. Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Related Res 1982;4:85-93.
  • Bjamason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228-33.
  • Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998;93:148390.
  • Jahnsen J, Falch JA, Mowinckel P, Aadland E. Ultrasound measurements of calcaneus for estimation of skeletal status in patients with inflammatory bowel disease. Scand J Gastroenterol 1999:34:790-7.
  • Cosman F, Nieves J, Herbert J, Shen V, Lindsay R. High-dose glucocorticoid s in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res 1994;9:1097-105.
  • Paz-Pacheco E, Fuleihan GE, LeBoff MS. Intact parathyroid hormone levels are not elevated in glucocorticoid-treate d subjects. J Bone Miner Res 1995;10:1713-8.
  • Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B. Osteomalacia after small-intestinal resection. Lancet 1978; 1(8054)5-12.
  • Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Stanton MR, Compston JE. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporosis International 1993;3:236-41.
  • Hessov I, Mosekilde L, Meisen F, Fasth S, Hütten L, Lund B, et al. Osteopenia with normal vitamin D metabolites after smallbowel resection for Crohn's disease. Scand J Gastroenterol 1984:19:691-6.
  • Lin CL, Moniz C, Chambers TJ, Chow JW. Colitis causes bone loss in rats through suppression of bone formation [see comments]. Gastroenterology 1996:111:1263-71.
  • Silvennoinen J, Risteli L, Karttunen T, Risteli J. Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut 1996:38:223-8.
  • Bischoff SC, Hermann A, Goke M, Manns MP, von zur Mühlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease [see comments]. Am J Gastroenterol 1997;92:1157-63.
  • Robinson RJ, Iqbal SJ, Abrams K, Al-Azzawi F, Mayberry JF. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998:12:699-705.
  • Schulte C, Dignass AU, Mann K, Goebell H. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflam Bowel Dis 1998;4: 268-75.
  • Schulte C, Dignass AU, Mann K, Goebell H. Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study. Scand J Gastroenterol 1999:34:696-702.
  • Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut 2000;46 Suppl l:11-8.
  • Valentine JF, Sninsky CA. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol 1999:94:878-83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.